EUVIMEDEUVIMED entdecken
Crossref

ANALISIS MEKANISME ANTIDIABETES SENYAWA JINTEN HITAM (Nigella sativa) MELALUI NETWORK PHARMACOLOGY APPROACH

Feyka Azzahra Herawan, Fatwah Normalita, Kamelia Azizahra, Maulidina Afrillia, Siti Nurpadilah Ramadani, Himyatul Hidayah, Aninda Nasuha

Jurnal Buana Farma · 30.06.2026 · 6 (2) · 352-363

DOI: 10.36805/jbf.v6i2.1731 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Jurnal Buana Farma, online erschienen am 30.06.2026. Verfasst von Feyka Azzahra Herawan und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetes mellitus is a metabolic disorder characterized by hyperglycemia resulting from impaired insulin secretion, insulin action, or a combination of both. The increasing prevalence of diabetes has encouraged the development of plant-based therapeutic agents capable of exerting multitarget effects. One promising medicinal plant is Nigella sativa, which contains various bioactive compounds with potential antidiabetic activity. This study aimed to analyze the antidiabetic mechanisms of secondary metabolites from Nigella sativa using a network pharmacology approach. The study was conducted in silico using several databases and bioinformatics tools, including KNApSAcK, PubChem, pkCSM, ADMETlab 3.0, SuperPred, GeneCards, Venny, STRING, and Cytoscape. The identification process revealed 47 secondary metabolites with available SMILES data. ADME and toxicity analyses showed that 34 compounds met the safety criteria, demonstrated good oral bioavailability, and were predicted to be non-mutagenic and non-hepatotoxic. Target prediction identified 178 protein targets and 598 glucose metabolism-related genes, with 25 overlapping genes identified through intersection analysis. Protein-protein interaction (PPI) network analysis indicated that PPARG was the primary hub gene, exhibiting the highest degree centrality, betweenness centrality, and closeness centrality values. Additionally, STAT3, FASN, HIF1A, SLC2A1, and GSK3B showed high connectivity within the network. The findings suggest that the bioactive compounds of Nigella sativa may exert multitarget antidiabetic effects through the regulation of insulin sensitivity, glucose metabolism, energy homeostasis, and lipid metabolism.

Zitieren

APA

Herawan, F. A., Normalita, F., Azizahra, K., Afrillia, M., Ramadani, S. N., Hidayah, H., & Nasuha, A. (2026). ANALISIS MEKANISME ANTIDIABETES SENYAWA JINTEN HITAM (Nigella sativa) MELALUI NETWORK PHARMACOLOGY APPROACH. Jurnal Buana Farma, 6(2), 352-363. https://doi.org/10.36805/jbf.v6i2.1731

Vancouver

Herawan FA, Normalita F, Azizahra K, Afrillia M, Ramadani SN, Hidayah H, et al. ANALISIS MEKANISME ANTIDIABETES SENYAWA JINTEN HITAM (Nigella sativa) MELALUI NETWORK PHARMACOLOGY APPROACH. Jurnal Buana Farma. 2026;6(2):352-363. doi:10.36805/jbf.v6i2.1731

BibTeX
@article{Herawan2026,
  author = {Herawan, Feyka Azzahra and Normalita, Fatwah and Azizahra, Kamelia and Afrillia, Maulidina and Ramadani, Siti Nurpadilah and Hidayah, Himyatul and Nasuha, Aninda},
  title = {ANALISIS MEKANISME ANTIDIABETES SENYAWA JINTEN HITAM (Nigella sativa) MELALUI NETWORK PHARMACOLOGY APPROACH},
  journal = {Jurnal Buana Farma},
  year = {2026},
  volume = {6},
  number = {2},
  pages = {352--363},
  doi = {10.36805/jbf.v6i2.1731}
}
Kostenlos starten →